KIM GENDRON: Open Payments
NPI 1053404061 · SCHAGHTICOKE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 7 payments from 5 companies in 2025. Trend: 2023 $120 · 2024 $0 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $129 |
| Novo Nordisk Inc | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: Auvelity, CAPLYTA, Ozempic, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
